Wilson was named COO of the Japanese firm’s American operation last September, Nihon Kohden said.
The move is part of a major reorganization aimed at responding to the dynamic U.S. healthcare market, Irvine, Calif.-based Nihon Kohden America said. Wilson, who was replaced last June at Monarch by former CapsuleTech chief marketing & sales officer Stuart Long, replaces Fumio Izumida at Nihon Kohden.
“Wilson is a person who shares a passion to contribute to the advancement of medicine with new technologies, which is essential to the corporate philosophy of Nihon Kohden. Upon joining our organization, he immediately began reshaping the corporate strategies based on his deep understanding of the unique needs of healthcare within the U.S. market. We believe he will demonstrate strong leadership to help the company achieve record growth in the coming months and years, and establish a robust foundation to provide better healthcare solutions to customers,” international operations director Hirokazu Ogino said in prepared remarks.
Nihon Kohden said its breaking down its former organizational structure, which was separated into product-specific businesses, and replacing it with “unified healthcare solutions that are designed to respond to the needs of customers and the market.”
“The healthcare market is becoming more consolidated to allow organizations to achieve efficiencies of scale that would not be possible as an individual hospital or physician’s office,” Constantine said in a press release. “At the same time, these organizations are looking for companies that can meet their needs across multiple departments. By changing the way we approach the market, we will be able to demonstrate both the breadth and depth of our technological innovations across the healthcare continuum.”
The company also tapped former Henry Schein (NSDQ:HSIC) sales vice president Michael Stone to be senior vice president of sales. Nihon Kohden American also named Kathy Hart vice president of marketing and Veffa Devers as vice president of clinical excellence programs. Thomas Bento was hired as senior vice president of regulatory & quality affairs and medtech veteran Betzy Estrada as director of human resources.
Staar Surgical (NSDQ:STAA)
said it promoted Hans Blickensdoerfer to the newly created role of international commercial operations president. Staar 1st hired Blickensdoerfer in 2005 and was most recently Europe, Middle East and Latin America president for the ophthalmology company.
Osiris Therapeutics promotes from within for CSO job
Osiris Therapeutics said it boosted Alla Danilkovitch to be its new chief scientific officer after 12 years with the regenerative medicine company.
CryoLife founder & chairman Anderson steps down
CryoLife Inc. (NYSE:CRY) said its founder & chairman, Steven Anderson, is retiring from all roles a the company effective immediately. President & CEO Pat Mackin, a Medtronic (NYSE:MDT) veteran, was named chairman as well.
At DeviceTalks Boston, Tyler Shultz will give attendees an inside look at Theranos and how he was able to sound the alarm after he realized the company was falling apart. Shultz will take attendees behind the story that everyone is talking about: the rise and fall of Elizabeth Holmes and her diagnostic company, Theranos.
Join Shultz and 1,000+ medical device professionals at the 8th annual DeviceTalks Boston.